Platform

Built for consistency, speed and scale

NuclearMediX is building a repeatable radiopharmaceutical platform designed to generate multiple diagnostic and therapeutic assets. We integrate chemistry, isotope selection, and manufacturing into a single system.

M

Modular Architecture

Targeting vector plus interchangeable radioactive module.

C

Click chemistry

Decouples fragile biological vectors from harsh radiolabelling conditions.

A

Automation-Ready

Cassette-enabled synthesis for reproducibility and good manufacturing practice (GMP)-aligned workflows.

F

18F-first strategy

Built for access, distribution reach, and dose scalability from day one.

How it works

A streamlined process from biology to radiotracer

Cassette v1.0 brings plug and play synthesis into a distributed manufacturing model.

  • 01Select Targetvalidated biology such as SSTR2
  • 02Pair Vectorpeptide, small molecule, or antibody fragment
  • 03Attach Handleclick handle for modular assembly
  • 04Click Labelradiolabelling with chosen module
  • 05Synthesisecassette-enabled standardised production
Patient access

The SSTR-targeted PET access challenge

Limited availability of SSTR-targeted PET tracers can delay diagnostic imaging and restrict access for patients and healthcare providers.

Diagnostic Delays

Tracer shortages can delay patient management and increase stress for people awaiting scans.

Production Limits

Short shelf-life and limited production capacity can restrict broad clinical availability.

Reliable Supply

The 18F platform is intended to support more consistent SSTR-targeted PET diagnostic agent supply.

Scalable Access

The model is designed for technology transfer to hospital and contract radiopharmacies.